Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...

Medicare's Transforming Episode Accountability Model is projected to save $46.6 million by 2030, with safety-net hospitals ...

Conclusions: Cancer costs for employers are not uniformly increasing, but instead, shifting based on market competition and therapeutic innovation. Where costs are rising, they are driven by novel ...

Employer-mandated high-deductible health plan enrollment was not associated with reduced use of oral targeted anticancer ...

MA-to-MA switching among dually eligible beneficiaries rose sharply from 2016 to 2022, AJMC study author Grace Mackleby, PhD, ...

Goad, PharmD, MPH, of Chapman University explains why pharmacists are trusted, accessible sources for COVID-19 vaccine ...

Michael Wechsler, MD, of National Jewish Health, discusses how twice yearly depemokimab reduces exacerbation risk in patients with T2 asthma. The findings suggest twice yearly dosing may offer early ...

Type 2 (T2)-high and T2-low asthma are distinguishable by unique transcriptomic networks, but characterization of T2-low asthma remains relatively poo ...

Gray market peptides cause vague symptoms patients may not disclose or link, so serious harms can go unnoticed until late, ...

Gray market peptides cause vague symptoms patients may not disclose or link, so serious harms can go unnoticed until late, says Catherine Varney, DO. 259 Prospect Plains Rd, Bldg H Cranbury, NJ 08512 ...

BC, discusses how data builds payer trust, reduces prior authorization, and expands access in community oncology. In one of its most recent pilots, AON partnered with Evolent Health and a specific ...

Telitacicept has the first regulatory approval for Sjögren disease (China), while global phase 3 programs aim to support ...